Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Definium Therapeutics (DFTX) recorded Liabilities and Shareholders Equity of $1.11 billion in Q2 2026, up 319.8% from $265.09 million a year earlier and up 177.3% from the prior quarter.

Analysis

Definium Therapeutics (DFTX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Definium Therapeutics reported Liabilities and Shareholders Equity of $440.1 million, up 45.7% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 40.1% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $302.15 million in FY2024 (+142.6%), $124.54 million in FY2023 (-26.7%), $169.99 million in FY2022 (+3.7%) and $164 million in FY2021 (+101.2%).
  • The Q2 2026 figure is the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2020.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased for three consecutive quarters, with growth averaging 81.6% over the last eight quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 319.8% in Q2 2026, against a decline of 26.7% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $401.29 million (Q1 2026), $440.1 million (Q4 2025) and $236.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 201.06 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 135.12 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 115.83 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 27.42 Bn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - 1.11 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Bn
Mar 31, 2026 401.29 Mn
Dec 31, 2025 440.10 Mn
Sep 30, 2025 236.92 Mn
Jun 30, 2025 265.09 Mn
Mar 31, 2025 275.32 Mn
Dec 31, 2024 302.15 Mn
Sep 30, 2024 319.77 Mn
Jun 30, 2024 268.15 Mn
Mar 31, 2024 275.53 Mn
Dec 31, 2023 124.54 Mn
Sep 30, 2023 141.55 Mn
Jun 30, 2023 142.09 Mn
Mar 31, 2023 155.53 Mn
Dec 31, 2022 169.99 Mn
Sep 30, 2022 180.91 Mn
Jun 30, 2022 134.28 Mn
Mar 31, 2022 149.23 Mn
Dec 31, 2021 164.00 Mn
Dec 31, 2020 81.52 Mn
API Access

Definium Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=DFTX&period=max&api_key=YOUR_API_KEY